Literature DB >> 15833088

Migraine: epidemiology, impact, and risk factors for progression.

Richard B Lipton1, Marcelo E Bigal.   

Abstract

Migraine is a chronic and sometimes progressive disorder characterized by recurrent episodes of headache and associated symptoms. This article reviews the epidemiology of and the risk factors for migraine described in population studies, and discusses the burden of disease and the socioeconomic costs of migraine. In the years prior to puberty, migraine is more common among boys than girls. By the onset of puberty, migraine is more prevalent in girls, and by the late teens, females are about twice as likely to suffer from migraine as males. The prevalence of migraine peaks in both sexes during the most productive years of adulthood (age 25 to 55 years) and, in the United States, the prevalence is higher in individuals of lower socioeconomic status. Direct costs of migraine include the cost of migraine medications and health care expenses. Indirect costs associated with migraine include reduced productivity due to absenteeism and reduced performance while at work. Recent evidence suggests that a subgroup of migraine patients may have a clinically progressive disorder. Future epidemiologic studies should focus on identifying patients who are at higher risk for progression and on assessing the impact of intervention strategies on disease progression.

Entities:  

Mesh:

Year:  2005        PMID: 15833088     DOI: 10.1111/j.1526-4610.2005.4501001.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  97 in total

Review 1.  Obesity and chronic daily headache.

Authors:  Marcelo E Bigal; Alan M Rapoport
Journal:  Curr Pain Headache Rep       Date:  2012-02

2.  Primary brain calcification: an international study reporting novel variants and associated phenotypes.

Authors:  Eliana Marisa Ramos; Miryam Carecchio; Roberta Lemos; Joana Ferreira; Andrea Legati; Renee Louise Sears; Sandy Chan Hsu; Celeste Panteghini; Luca Magistrelli; Ettore Salsano; Silvia Esposito; Franco Taroni; Anne-Claire Richard; Christine Tranchant; Mathieu Anheim; Xavier Ayrignac; Cyril Goizet; Marie Vidailhet; David Maltete; David Wallon; Thierry Frebourg; Lylyan Pimentel; Daniel H Geschwind; Olivier Vanakker; Douglas Galasko; Brent L Fogel; A Micheil Innes; Alison Ross; William B Dobyns; Diana Alcantara; Mark O'Driscoll; Didier Hannequin; Dominique Campion; João R Oliveira; Barbara Garavaglia; Giovanni Coppola; Gaël Nicolas
Journal:  Eur J Hum Genet       Date:  2018-06-28       Impact factor: 4.246

3.  Chiropractic spinal manipulative treatment of migraine headache of 40-year duration using Gonstead method: a case study.

Authors:  Aleksander Chaibi; Peter J Tuchin
Journal:  J Chiropr Med       Date:  2011-08-06

4.  Treatment of bipolar disorder with comorbid migraine.

Authors:  Abigail Ortiz; Martin Alda
Journal:  J Psychiatry Neurosci       Date:  2010-01       Impact factor: 6.186

Review 5.  White matter hyperintensities: from medical comorbidities to bipolar disorders and back.

Authors:  Eva Gunde; Ryan Blagdon; Tomas Hajek
Journal:  Ann Med       Date:  2011-07-13       Impact factor: 4.709

6.  Vitamin D in migraine headache: a comprehensive review on literature.

Authors:  Zeinab Ghorbani; Mansoureh Togha; Pegah Rafiee; Zeynab Sadat Ahmadi; Reyhaneh Rasekh Magham; Samane Haghighi; Soodeh Razeghi Jahromi; Maryam Mahmoudi
Journal:  Neurol Sci       Date:  2019-08-03       Impact factor: 3.307

Review 7.  A new era in headache treatment.

Authors:  Michail Vikelis; Konstantinos C Spingos; Alan M Rapoport
Journal:  Neurol Sci       Date:  2018-06       Impact factor: 3.307

8.  Neurofeedback and biofeedback with 37 migraineurs: a clinical outcome study.

Authors:  Deborah A Stokes; Martha S Lappin
Journal:  Behav Brain Funct       Date:  2010-02-02       Impact factor: 3.759

9.  Effect of biofeedback-assisted autogenic training on headache activity and mood states in Korean female migraine patients.

Authors:  Eun-Ho Kang; Joo-Eon Park; Chin-Sang Chung; Bum-Hee Yu
Journal:  J Korean Med Sci       Date:  2009-09-23       Impact factor: 2.153

10.  Prophylatic treatment of migraine and migraine clinical variants with topiramate: an update.

Authors:  Sergio Carmona; Osvaldo Bruera
Journal:  Ther Clin Risk Manag       Date:  2009-08-20       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.